Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10786501
Treatment of prostate cancer
granted -
US 10786545
Use of peptides that block metadherin-SND1 interaction as treatment for cancer
granted -
US 10780097
Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
granted -
US 10772828
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
granted -
US 10772865
Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
granted -
US 10772880
Method of treatment with tradipitant
granted -
US 10766869
Triazoles for the treatment of demyelinating dieases
granted -
US 10768167
Plasma membrane citrate transporter for use in the diagnosis and treatment of cancer
granted -
US 10766864
Morphinan derivatives for the treatment of neuropathic pain
granted -
US 10767179
MicroRNA composition for the treatment of neuroblastoma
granted -
US 10765666
Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering
granted -
US 10760076
Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
granted -
US 10758595
Treatment of retinitis pigmentosa using engineered meganucleases
granted -
US 10758496
Estrogen receptor ligand treatment for neurodegenerative diseases
granted -
US 10751348
Formulations of testosterone and methods of treatment therewith
granted -
US 10751332
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
granted -
US 10745475
Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics
granted -
US 10744116
Detection and treatment of anti-PD-1 therapy resistant metastatic melanomas
granted -
US 10738305
Materials and methods for treatment of hemoglobinopathies
granted -
US 10736857
Treatment of pervasive developmental disorders with redox-active therapeutics
granted -
US 10737995
Nuclear receptor modulators and their use for the treatment and prevention of cancer
granted -
US 10729815
Combined treatment for nerve injuries
granted -
US 10729753
Compositions and methods for treatment of homocystinuria
granted -
US 10729693
Compositions and methods for the treatment of endometriosis
granted